Jeffrey F Horowitz Selected Research

Enzymes

4/2011	High muscle lipid content in obesity is not due to enhanced activation of key triglyceride esterification enzymes or the suppression of lipolytic proteins.
6/2007	Acute exercise increases triglyceride synthesis in skeletal muscle and prevents fatty acid-induced insulin resistance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jeffrey F Horowitz Research Topics

Disease

23	Insulin Resistance 01/2020 - 07/2004
12	Obesity 01/2021 - 04/2002
6	Inflammation (Inflammations) 11/2018 - 02/2013
5	Type 2 Diabetes Mellitus (MODY) 01/2020 - 05/2011
4	Overweight 01/2018 - 01/2009
3	Weight Loss (Weight Reduction) 01/2020 - 10/2009
3	Fibrosis (Cirrhosis) 11/2017 - 05/2017
3	Hyperphagia (Overeating) 05/2013 - 03/2011
2	Body Weight (Weight, Body) 01/2020 - 10/2009
2	Metabolic Diseases (Metabolic Disease) 01/2018 - 07/2017
2	Non-alcoholic Fatty Liver Disease 07/2017 - 05/2017
2	Hyperlipidemias (Hyperlipidemia) 04/2008 - 06/2006
1	Lipodystrophy 01/2021
1	Morbid Obesity 01/2020
1	Weight Gain 07/2018
1	Hypoxia (Hypoxemia) 11/2017
1	Fatty Liver 07/2017
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2012
1	Hyperinsulinism (Hyperinsulinemia) 03/2011
1	Abdominal Obesity 04/2002
1	Starvation 04/2002

Drug/Important Bio-Agent (IBA)

15	Fatty Acids (Saturated Fatty Acids)IBA 11/2018 - 07/2004
10	Glucose (Dextrose)FDA LinkGeneric 01/2020 - 03/2005
9	Proteins (Proteins, Gene)FDA Link 01/2021 - 04/2002
9	LipidsIBA 01/2018 - 03/2005
7	Insulin (Novolin)FDA Link 02/2018 - 06/2007
4	IronIBA 01/2021 - 11/2018
4	Triglycerides (Triacylglycerol)IBA 10/2017 - 06/2007
3	Ferritins (Ferritin)IBA 01/2021 - 11/2018
3	CarbohydratesIBA 01/2018 - 04/2008
2	LeptinIBA 01/2021 - 05/2011
2	C-Reactive ProteinIBA 11/2018 - 01/2016
2	Messenger RNA (mRNA)IBA 07/2018 - 11/2017
2	Dietary Fats (Dietary Fat)IBA 01/2018 - 07/2004
2	Pharmaceutical PreparationsIBA 07/2017 - 06/2014
2	Growth Hormone (Somatotropin)IBA 11/2012 - 03/2011
2	EnzymesIBA 04/2011 - 06/2007
2	Dietary Carbohydrates (Carbohydrate, Dietary)IBA 03/2010 - 07/2004
2	IsotopesIBA 03/2010 - 04/2002
1	Transferrin Receptors (Transferrin Receptor)IBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Oxygen (Dioxygen)IBA 01/2020
1	HepcidinsIBA 11/2018
1	TransferasesIBA 01/2018
1	AcidsIBA 01/2018
1	Aspartic Acid (Aspartate)FDA Link 01/2018
1	CholesterolIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 11/2017
1	amlexanox (Aphthasol)FDA Link 07/2017
1	Phosphotransferases (Kinase)IBA 07/2017
1	nasIBA 05/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2016
1	HDL LipoproteinsIBA 01/2016
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2016
1	Oleic Acid (Oleate)IBA 01/2016
1	CytokinesIBA 07/2014
1	Insulin Receptor Substrate ProteinsIBA 06/2014
1	PalmitatesIBA 09/2013
1	JNK Mitogen-Activated Protein KinasesIBA 05/2013
1	SphingolipidsIBA 02/2013
1	oxidized low density lipoproteinIBA 02/2013
1	CeramidesIBA 02/2013
1	Glycerol (Glycerine)FDA LinkGeneric 05/2011
1	Perilipin-1IBA 04/2011
1	ChylomicronsIBA 06/2006
1	Amino Acids FDA Link 04/2002

Therapy/Procedure

3	Therapeutics 01/2021 - 05/2011
1	Injections 11/2012
1	Aftercare (After-Treatment) 05/2011